Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
9.78M
-
Shares change
-
+557K
-
Total reported value, excl. options
-
$66.5M
-
Value change
-
+$3.71M
-
Number of buys
-
21
-
Number of sells
-
-15
-
Price
-
$6.80
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2017
43 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2017.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.78M shares
of 60M outstanding shares and own 16.29% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.09M shares), FMR LLC (1.61M shares), SPHERA FUNDS MANAGEMENT LTD. (1.04M shares), 683 Capital Management, LLC (915K shares), MILLENNIUM MANAGEMENT LLC (716K shares), Vanguard Group Inc (699K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (693K shares), MANGROVE PARTNERS (164K shares), Knoll Capital Management, LP (124K shares), and Hikari Power Ltd (108K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.